Valuation: TherapeuticsMD, Inc.

Market Cap 20.83M 18.7M 17.27M 15.66M 29.26M 1.98B 29.62M 207M 82.21M 1.04B 78.2M 76.53M 3.29B P/E 2024
-4.55x
P/E 2025 -30.9x
Enterprise Value 19.45M 17.45M 16.12M 14.61M 27.32M 1.85B 27.65M 193M 76.74M 968M 73M 71.44M 3.07B EV / Sales 2024
6.83x
EV / Sales 2025 5.78x
Free-Float
90.96%
Yield 2024 *
-
Yield 2025 -
1 day+0.30%
1 week-3.97%
Current month-11.06%
1 month-13.62%
3 months-12.78%
6 months-12.78%
Current year+10.76%
1 week 1.76
Extreme 1.76
1.91
1 month 1.75
Extreme 1.75
2.12
Current year 1.58
Extreme 1.58
2.95
1 year 1.11
Extreme 1.11
2.95
3 years 0.7
Extreme 0.7
3.07
5 years 0.7
Extreme 0.7
39.7
10 years 0.7
Extreme 0.7
414.76
Manager TitleAgeSince
Chief Executive Officer 51 2022-12-29
Director of Finance/CFO 52 2023-08-16
Director TitleAgeSince
Director/Board Member 46 2012-02-28
Chairman 83 2012-04-15
Director/Board Member 69 2020-03-19
Date Insider Type Main position Quantity % Market Cap. Importance
12/23/25 Buy

Chairman

8,400 0.0726%
11/3/25 Free

Chairman

8,500 0.0734%
11/3/25 Free

Director

8,500 0.0734%
Change 5-day change 1-year change 3-year change Capi.($)
-1.11%-3.97%+37.82%-10.18% 20.83M
+0.22%-0.11%+55.16%+128.89% 1,140B
+0.91%+3.62%+41.23%+84.59% 641B
-0.10%-0.91%+25.62%+106.18% 507B
+0.63%+2.33%+49.21%+67.82% 383B
+0.86%-4.38%+61.14%+37.92% 347B
+1.02%+1.80%+24.84%+53.75% 293B
-0.25%+1.62%+2.20%+26.65% 266B
+0.75%+2.07%+53.87%+71.28% 240B
+0.25%+1.63%+32.03%+107.60% 197B
Average +0.28%+2.31%+38.31%+67.45% 401.38B
Weighted average by Cap. +0.35%+2.98%+42.22%+88.50%

Financials

2024 2025
Net sales 1.76M 1.58M 1.46M 1.32M 2.47M 167M 2.5M 17.5M 6.95M 87.68M 6.61M 6.47M 278M 3.02M 2.71M 2.5M 2.27M 4.24M 287M 4.3M 30.03M 11.92M 150M 11.34M 11.1M 477M
Net income -2.18M -1.96M -1.81M -1.64M -3.06M -207M -3.1M -21.67M -8.61M -109M -8.19M -8.01M -344M -569K -511K -472K -428K -799K -54.05M -809K -5.65M -2.25M -28.33M -2.14M -2.09M -89.84M
Net Debt 2.12M 1.9M 1.75M 1.59M 2.97M 201M 3.01M 21.02M 8.35M 105M 7.94M 7.77M 334M -1.39M -1.24M -1.15M -1.04M -1.95M -132M -1.97M -13.77M -5.47M -69.01M -5.2M -5.09M -219M
Projected Income Statement - Annual - TherapeuticsMD, Inc.
Logo TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
Employees
1
Date Price Change Volume
26-10-27 US$1.780 -1.11% 7,103
26-10-26 US$1.800 0.00% 6,387
26-10-23 US$1.800 -2.70% 15,707
26-10-22 US$1.850 -2.63% 5,654
26-10-21 US$1.900 +1.06% 6,504
  1. Stock Market
  2. Stocks
  3. TXMD Stock